{"public_id":"co_315be32242a252a72e64a30091497054","status":"active","merged_into_public_id":null,"resolved_public_id":"co_315be32242a252a72e64a30091497054","name":"time to treatment discontinuation","description":"The interval from treatment initiation until the injected antipsychotic was stopped.","aliases":["treatment duration"],"types":["outcome"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":22471512,"title":"Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients","citation_count":9,"url":"https://sah.borca.ai/papers/22471512"}],"claims":[{"public_id":"cl_5e51be55f0f32e5e213303d86849f7f6","text":"A trend favored paliperidone palmitate for time to treatment discontinuation, but the result was affected by patients switching between the two injections.","corpus_id":22471512,"url":"https://sah.borca.ai/claims/cl_5e51be55f0f32e5e213303d86849f7f6"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_315be32242a252a72e64a30091497054","url":"https://sah.borca.ai/concepts/co_315be32242a252a72e64a30091497054"}